The global EPA and DHA formula market is a cornerstone of the global wellness and specialized nutrition economy, valued at 2,397.5 USD Million in 2024. As scientific consensus strengthens regarding the neuroprotective and cardiovascular benefits of Omega-3 fatty acids, the sector is projected to reach 4,500 USD Million by 2035.
GLOBAL SUPPLY CHAIN & MARKET DISRUPTION ALERT
Escalating geopolitical tensions in the Middle East, particularly around the Strait of Hormuz and the Red Sea, are creating significant disruptions across global energy, chemicals, and logistics markets. Critical shipping corridors are under pressure, with major oil, LNG, petrochemical, and raw material flows at risk, triggering supply chain delays, freight cost surges, insurance withdrawals, and heightened price volatility. These disruptions are increasing operational risks and cost uncertainties for industries dependent on global trade routes and energy-linked feedstocks.
Access our real-time disruption analysis covering supply chain risks, price outlook scenarios, logistics impacts, and alternative sourcing strategies.
👉 Request a Sample Report to understand the potential impact on your industry and get actionable insights to support procurement, risk management, and supply chain planning. Contact us today to receive the latest market intelligence and mitigation strategies.
Market Overview & 2026 Milestones
-
Current Market Size (2024): 2,397.5 USD Million.
-
Projected Market Size (2035): 4,500 USD Million.
-
Growth Rate (CAGR): 5.9% (2025–2035).
-
2026 Valuation: Prior to the current geopolitical crisis, the market was on track to reach 2,688.7 USD Million by the end of 2026.
Get Sample Report PDF | https://www.wiseguyreports.com/sample-request?id=615187
Key Market Insights
The global EPA and DHA formula industry size was 2,538.9 USD Million in 2025 and is projected to grow from 2,688.7 USD Million in 2026 to 4,500 USD Million by 2035, exhibiting a CAGR of 5.9% during the forecast period. This trajectory is being redefined by the “Plant-Based Omega Shift” in early 2026. As sustainability concerns over fish stocks grow, the demand for Algal Oil as a primary source of EPA and DHA has surged. Furthermore, the Circular Economy is influencing the sector through the upcycling of fish processing by-products, helping to stabilize supply chains amid volatile 2026 maritime trade conditions.
Detailed Segment Analysis
By Source
-
Fish Oil: Traditionally the dominant segment, though facing pricing pressure due to 2026 supply chain bottlenecks and environmental quotas.
-
Algal Oil: The fastest-growing source in 2026, favored by the vegan demographic and infant formula manufacturers for its high purity and low contaminant risk.
-
Krill Oil: Gaining traction in the premium dietary supplement tier for its superior phospholipid bioavailability.
By Application
-
Infant Formula: A critical application area where DHA is increasingly mandated by global health regulators for cognitive development.
-
Dietary Supplements & Pharmaceuticals: High-volume segments driven by an aging population seeking heart and joint health support.
-
Functional Food and Beverages: Growing inclusion in everyday products like milk, juices, and bread.
By Form
-
Softgels & Capsules: The preferred format for dietary supplements due to superior oxidation protection and ease of consumption.
-
Liquid & Powder: Essential for infant formula and functional food fortification.
Regional Insights
-
North America: Leading the market in high-purity pharmaceutical-grade EPA/DHA applications and advanced softgel technology.
-
Asia-Pacific: Retains the largest consumer base, driven by massive infant formula demand in China and Southeast Asia and a growing awareness of geriatric nutrition in Japan.
-
Europe: Focused heavily on sustainability and “clean label” sourcing, driving the global transition toward certified sustainable marine oils and algal alternatives.
Drivers & Challenges
-
Driver 1: Cognitive Health Awareness. Increasing clinical evidence supporting Omega-3s for prenatal development and geriatric mental health is fueling steady demand.
-
Driver 2: Expansion of Algal Biotechnology. Breakthroughs in fermentation are making algal-derived EPA/DHA more cost-competitive with traditional fish oil.
-
Hurdle 1: Logistics & Freight Costs. Red Sea disruptions have extended lead times for bulk oil shipments, increasing the landed cost of raw materials by an estimated 15-20%.
-
Hurdle 2: Marine Biodiversity Regulations. Stricter 2026 fishing quotas aimed at ocean conservation are tightening the global supply of high-yield fish oil.
More Related Insight
FAQ
1. What is the projected CAGR for the EPA and DHA formula market?
The market is expected to grow at a CAGR of 5.9% from 2025 to 2035.
2. How are current maritime disruptions affecting prices?
Logistics bottlenecks in the Middle East have increased freight insurance and fuel surcharges, leading to a rise in the retail price of Omega-3 supplements.
3. Why is algal oil becoming more popular in 2026?
Algal oil is sustainable, vegan-friendly, and free from ocean-borne contaminants like microplastics and heavy metals, making it a premium choice for infant nutrition.
4. What is the expected market valuation by 2035?
The global market is projected to reach a valuation of 4,500 USD Million by 2035.
5. Which region dominates the EPA and DHA market?
The Asia-Pacific region holds the largest market share, primarily due to the high volume of the infant formula and functional food sectors.
